E25

0.00%

34.0¢ element 25 limited

Tesla taking up a position/Offtake would be quite the coup...A...

First 11 Last

Share
Profile

Follow
srood

2,765 Posts.

951

05/02/24

11:41

Post #: 72239032
Share

Originally posted by WhatsTheTip: ↑

I think its far more possible than is reflected in the share price, but there's still no certainty HPMSM will progress. The share price basically says that HPMSM won't happen or won't happen on financials that look anything close to that proposed in scoping studies. A fully owned single train HPMSM plant is modelled to generate circa A$100m of EBITDA each year starting in only a couple of years. Two trains are US$155m EBITDA. Clearly if the market thought that would happen with high or full E25 ownership, E25 would have a multi-hundred million market cap (before factoring in any value to Butcherbird). The MC is massively below that so you are not alone in having doubts.

The key to why something is likely is the Inflation Reduction Act. If a company can secure all the battery minerals, jump through the percentage hoops and avoid China in doing so, they get a US$7,500 tax credit for their customer purchasers of EV's. You can have a sticker price of US$40,000 and be "cheaper" than someone selling a product at US$35,000 that doesn't allow the tax credit. If you are close to completing your supply chain, the last missing link could cost your customers hundreds of millions. To be priced competitively that cascades back to less profits/higher losses (many OEMs will have early EV phase losses). Say you were planning to selling 100kt of EV's each year (which is a modest volume for the US market). Your customer value proposition on those sales is improved by $750m / yr by having a complete supply chain. That's a lot of reasons for closing the Manganese gap in your supply chain. If doing NMC batteries you need Lithium, Nickel, Manganese and Cobalt and Graphite. If going for the chunkier density that LMFP delivers over LFP, you also need lots of Manganese in the form of HPMSM.

A modest one-off investment to assist E25's project into production gets rid of one of these problematic metals. Both General Motors and Stellantis have realised this problem and want E25's project to progress so they have a solution. This isn't your typical situation where a project stalls because of a low share price.

One of the huge wildcards is where Telsa is going to get IRA compliant HPMSM from (making the presumption they will want to make IRA compliant vehicles). Who is going to produce that HPMSM and where? If its E25, what does that mean for the share price? If its someone else, does that effectively take all their supply off the market for all remaining OEM's?

Expand

Tesla taking up a position/Offtake would be quite the coup...
A 3rd OT is on the cards and needed imo prior to Funding to get the ball rolling.

E25 Price at posting: 27.5¢ Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 9 more messages in this thread...

First 11 Last

Add E25 (ASX) to my watchlist

(20min delay)
Last 34.0¢		Change 0.000(0.00%)		Mkt cap ! $74.77M

Open	High	Low	Value	Volume
34.0¢	34.0¢	31.5¢	$153.5K	464.6K

Buyers (Bids)

No.	Vol.	Price($)
3	7500	32.5¢

Sellers (Offers)

Price($)	Vol.	No.
34.0¢	25527	1

View Market Depth

No.	Vol.	Price($)
1	31250	0.320
2	55455	0.315
2	4814	0.310
4	86527	0.305
10	146661	0.300

Price($)	Vol.	No.
0.340	25527	1
0.345	50000	2
0.350	13157	1
0.355	100000	1
0.360	8000	1

Last trade - 16.10pm 04/10/2024 (20 minute delay)

E25 (ASX) Chart

Tesla taking up a position/Offtake would be quite the coup...A...

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Tesla taking up a position/Offtake would be quite the coup...A...

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News